Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Mary Priyanka Udumula, Faraz Rashid, Harshit Singh, Tim Pardee, Sanjeev Luther, Tanya Bhardwaj, Km Anjaly, Sofia Piloni, Miriana Hijaz, Radhika P. Gogoi, Philip A. Philip, Adnan R. Munkarah, Shailendra Giri, Ramandeep Rattan
This study shows CPI-613 reduces tumor growth in chemoresistant ovarian tumors by inhibiting mitochondrial function and enhancing chemotherapy response.
Journal of Ovarian Research · Nov 14, 2024Peer-reviewedCancer Biology